They are also misused constantly
The Ozempic brand alone rose from fewer than 150,000 Medicare Part D users in 2019 to almost 2 million in 2024, per a study by independent research group KFF
Our healthcare team can help you decide if these medications fit your needs and health history
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
Dysbiosis can promote pathology by disrupting barrier integrity, driving chronic inflammation and immune dysregulation, producing bioactive metabolites, modulating host signaling pathways, and, in some cases, generating genotoxins that directly damage host DNA
GLP-1 changes also extend into some of the most personal domains: mood and thought